Catégorie : Substances psychédéliques et therapeutique

Inside bad trips : Exploring extra-pharmacological factors, Genis ONA, 2018

Inside bad trips : Exploring extra-pharmacological factors Genis ONA Journal of Psychedelic Studies, 2018, 2, (1), pp. 53–60 DOI: 10.1556/2054.2018.001   Objective : This study aimed to clarify the influence of extra-pharmacological factors in the etiology of bad trips, a common adverse reaction related to the consumption of psychedelic drugs. Methods : A descriptive approach was adopted. The information was collected using a web-based survey. The survey respondents volunteered to participate based on the condition that they had suffered a bad trip in the past. Results : This report reveals some variables that are commonly related to this adverse reaction (i.e., the recreational consumption of drugs, the [...]

Lire la suite

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment, Eduardo Ekman SCHENBERG et al., 2017

A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment EDUARDO EKMAN SCHENBERG, MARIA ANGÉLICA DE CASTRO COMIS, JOÃO FELIPE MOREL ALEXANDRE, LUÍS FERNANDO TÓFOLI, BRUNO DANIEL RASMUSSEN CHAVES, DARTIU XAVIER DA SILVEIRA Journal of Psychedelic Studies, 2017, 1, (2), pp. 74–83 DOI: 10.1556/2054.01.2017.007   Objective : This report documents the phenomenology of the subjective experiences of 22 patients with substancerelated disorders who were involved in a treatment combining cognitive–behavioral therapy and hospital sessions with ibogaine in Brazil. Methods: Participants underwent a one-to-one semi structured interview exploring the subjective effects of ibogaine. We employed interpretative phenomenological analysis [...]

Lire la suite

Perceptions of the medicinal value of hallucinogenic drugs among college students, Jared I. WILDBERGER et al., 2017

Perceptions of the medicinal value of hallucinogenic drugs among college students JARED I. WILDBERGER, CASSANDRA N. JOHN and ROBERT M. HALLOCK Journal of Psychedelic Studies, 2017, 1(2), pp. 50–54 DOI: 10.1556/2054.01.2017.008   Background : This survey examined perceptions among college students about the potential medicinal benefits of hallucinogenic drugs. Current research and potential benefits include an ability to help anxiety, post-traumatic stress disorder, and addiction with hallucinogen-assisted psychotherapy. Methods : We devised and administered a survey on 124 students at two college campuses, one small private college in the mid-Atlantic and one medium-sized public university in the Midwest of the United States. Results: Responses were similar [...]

Lire la suite

The hyperassociative mind : The psychedelic experience and Merleau-Ponty’s “wild being”, Csaba SZUMMER et al., 2017

The hyperassociative mind: The psychedelic experience and Merleau-Ponty’s “wild being” CSABA SZUMMER, LAJOS HORVÁTH, ATTILA SZABÓ, EDE FRECSKA and KRISTÓF ORZÓI Journal of Psychedelic Studies, 2017, 1, (2), pp. 55–64 DOI: 10.1556/2054.01.2017.006   Purpose : In contemporary phenomenology, Dieter Lohmar has suggested that the new task of phenomenological research is to analyze the “alternative representational systems” of fantasy. In line with this program, we propose that psychedelic experience could also be suitable subject to this project subsumed under the wider category of fantasy activity. The aim of this paper is to show that psychedelic experiences offer a favorable situation to study the imagination. Method : The [...]

Lire la suite

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder ?, Ben SESSA, 2017

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder ? Ben SESSA Journal of Psychedelic Studies, 2017,  1, (1), pp. 1–9 DOI: 10.1556/2054.01.2016.003   Treating people with alcohol use disorder has been an important target area for psychedelic research – both in the first studies of the 1950s and during the Psychedelic Renaissance of the last 10 years. To date, most studies have looked at the classical psychedelic drugs as adjuncts to psychotherapy; with attention paid to the psychospiritual aspect of the experience as a central therapeutic process in effecting abstinence from drinking. Psychotherapy assisted with 3,4,-methylenedioxymethamphetamine (MDMA) has never been explored for treating [...]

Lire la suite

Treating drug dependence with the aid of ibogaine: A qualitative study, Eduardo EKMAN SCHENBERG et al., 2017

Treating drug dependence with the aid of ibogaine: A qualitative study EDUARDO EKMAN SCHENBERG, MARIA ANGÉLICA DE CASTRO COMIS, JOÃO FELIPE MOREL ALEXANDRE, BRUNO DANIEL RASMUSSEN CHAVES, LUÍS FERNANDO TO´ FOLI and DARTIU XAVIER DA SILVEIRA Journal of Psychedelic Studies, 2017, 1, (1), pp. 10–19 DOI: 10.1556/2054.01.2016.002   Background : Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular [...]

Lire la suite

The antiaddictive effects of ibogaine: A systematic literature review of human studies, Rafael G. DOS SANTOS et al., 2017

The antiaddictive effects of ibogaine : A systematic literature review of human studies Rafael G. DOS SANTOS, José Carlos BOUSO and Jaime E. C. HALLAK Journal of Psychedelic Studies, 2017, 1, (1), pp. 20–28 DOI: 10.1556/2054.01.2016.001   Background and aims : Ibogaine is a naturally occurring hallucinogenic alkaloid with a therapeutic potential for reducing drug craving and withdrawal. To the best of our knowledge, no systematic review was previously performed assessing these effects. Thus, we conducted a systematic literature review of human studies assessing the antiaddictive effects of ibogaine. Methods : Papers published up to July 2, 2016 were included from PubMed, LILACS, and SciELO databases [...]

Lire la suite

Detoxification from methadone using low, repeated, and increasing doses of ibogaine : A case report, Clare WILKINS et al., 2017

Detoxification from methadone using low, repeated, and increasing doses of ibogaine : A case report CLARE WILKINS, RAFAEL G. DOS SANTOS, JORDI SOLÁ, MARC AIXALÁ, PEP CURA, ESTEFANÍA MORENO, MIGUEL ÁNGEL ALCÁZAR-CÓRCOLES, JAIME E. C. HALLAK and JOSÉ CARLOS BOUSO Journal of Psychedelic Studies,  2017, 1, (1), pp. 29–34 DOI: 10.1556/2054.01.2017.005   Background and aims : Ibogaine is a natural alkaloid that has been used in the last decades as an adjuvant for the treatment of opiate withdrawal. Despite the beneficial results suggested by animal studies and case series, there is a lack of clinical trials to assess the safety and efficacy of ibogaine. Moreover, [...]

Lire la suite

Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder : A case report, Rafael G. Dos Santos et al., 2017

Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder : A case report Rafael G. DOS SANTOS, Flavia L. OSÓRIO, José Alexandre S. CRIPPA and Jaime E. C. HALLAK Journal of Psychedelic Studies, 2017,  1, (1), pp. 35–39 DOI: 10.1556/2054.01.2017.004   Background and aims : Ayahuasca is a dimethyltryptamine- and β-carboline-rich hallucinogenic beverage traditionally used by indigenous groups of Northwest Amazonian for ritual and therapeutic purposes. Animal and human studies suggest that ayahuasca has antidepressant and anxiolytic potentials and has a good safety profile. However, anxiety-like reactions may also occur after ayahuasca intake, although they are rare. Methods [...]

Lire la suite

Subjective effectiveness of ibogaine treatment for problematic opioid consumption : Short- and long-term outcomes and current psychological functioning, Alan K. Davis et al., 2017

Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning ALAN K. DAVIS, JOSEPH P. BARSUGLIA, MARLEY WINDHAM-HERMAN, MARTA LYNCH and MARTIN POLANCO Journal of Psychedelic Studies, 2017, 1, (2), pp. 65–73 DOI: 10.1556/2054.01.2017.009   Background and aims : Very few studies have reported the effectiveness of ibogaine as a treatment for chronic opioid use. Therefore, this study evaluated the acute subjective effects of ibogaine, outcomes on problematic opioid consumption, and the long-term associations with psychological functioning. Methods : Using online data collection, 88 patients who received ibogaine treatment in Mexico between 2012 and 2015 completed our survey. Results : [...]

Lire la suite